Frontiers in Cardiovascular Medicine is a leading open-access journal published by FRONTIERS MEDIA SA, dedicated to advancing research in the field of cardiology and cardiovascular medicine. Since its inception in 2014, the journal has become a vital platform for the dissemination of high-quality research, boasting a commendable Q2 rank in the 2023 category for Cardiology and Cardiovascular Medicine. With a focus on promoting innovative studies and clinical insights, Frontiers in Cardiovascular Medicine facilitates open access to its content, allowing researchers, healthcare professionals, and students from around the globe to engage with the latest findings which are critical for the advancement of cardiovascular health. The journal's significant presence in the academic landscape, as indicated by its Scopus ranking (161/387 and 58th percentile), underscores its importance as a research outlet in this essential field. Located in Lausanne, Switzerland, the journal continues to support the global cardiovascular community by encouraging collaboration and knowledge sharing to address the challenges faced in cardiovascular medicine today.

The Hellenic Journal of Cardiology, a peer-reviewed open-access publication under the esteemed ELSEVIER banner, proudly represents the forefront of research in the field of Cardiology and Cardiovascular Medicine. Established in 1993 and actively publishing since then, this journal has carved a niche in disseminating high-quality research and clinical insights relevant to cardiovascular health in Greece and beyond. With an impressive Q2 ranking in both Cardiology and Cardiovascular Medicine categories as of 2023, the journal holds a commendable position at Rank #126/387 in Scopus, indicative of its critical role in advancing scientific knowledge and practice. The Hellenic Journal of Cardiology transitioned to open access in 2016, ensuring that ground-breaking research is freely accessible, fostering a global dialogue among researchers, clinicians, and students alike. Its publication frequency spans significant years, providing a continuous flow of innovative findings while addressing pressing cardiovascular issues. As the journal builds on its legacy, it aspires to enrich the academic community's understanding of cardiovascular medicine, making it an invaluable resource for anyone invested in heart health.

Expert Review of Cardiovascular Therapy is a leading academic journal published by TAYLOR & FRANCIS INC, focusing on innovative and impactful research in the field of cardiovascular medicine. With an ISSN of 1477-9072 and an E-ISSN of 1744-8344, this journal serves as an essential resource for researchers, clinicians, and educators, offering a platform for the dissemination of critical advancements in cardiovascular therapy and internal medicine. Since its inception in 2003, the journal has maintained a reputable standing with a Q2 ranking in various categories including Cardiology and Cardiovascular Medicine, reflecting its influence and rigor in the field. The journal, which is based in the United Kingdom, does not currently offer Open Access options, ensuring that its content is accessible primarily to subscribers. With its commitment to high-quality, peer-reviewed articles, Expert Review of Cardiovascular Therapy is dedicated to bridging the gap between experimental research and clinical application, thereby enhancing patient care and therapeutic outcomes in cardiovascular health.

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.

Welcome to the Journal of Cardiovascular Medicine, a leading platform for the dissemination of high-quality research in the field of cardiology and cardiovascular medicine. Published by Lippincott Williams & Wilkins, this esteemed journal boasts an ISSN of 1558-2027 and an E-ISSN of 1558-2035, reflecting its commitment to accessible and innovative cardiovascular research. With a significant impact factor and ranked Q2 in both Cardiology and Cardiovascular Medicine as well as in Medicine (Miscellaneous) for 2023, the journal is recognized for its contributions to advancing knowledge and practice in this critical area of health. The journal disseminates original research, reviews, and clinical studies, aimed at clinicians, researchers, and healthcare professionals who are dedicated to improving cardiovascular health outcomes. With a continuous commitment to evolving research from 2006 to 2024, the journal is an essential resource for those looking to stay at the forefront of the latest discoveries and methodologies in cardiovascular medicine.

Aktuelle Kardiologie is a premier journal in the field of cardiology, published by GEORG THIEME VERLAG KG. With its ISSN 2193-5203 and E-ISSN 2193-5211, it serves as an essential resource for cardiologists, researchers, and healthcare professionals who seek to stay abreast of the latest developments in cardiovascular medicine. Although currently not open access, the journal provides comprehensive insights through its rigorous peer-review process, ensuring high-quality content for its readers. Located in Stuttgart, Germany, the journal’s objectives include fostering the exchange of innovative research, clinical findings, and expert opinions that can significantly enhance patient care and inspire further studies in cardiovascular health. In an era where cardiovascular diseases are a leading public health concern, Aktuelle Kardiologie remains a vital platform for disseminating critical knowledge and advancing the field.

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Kardiologie is an emerging journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by SPRINGER HEIDELBERG in Germany. Established with the first issue in 2022, this journal provides a valuable platform for the dissemination of innovative research, clinical studies, and review articles that contribute to both theoretical knowledge and practical applications in cardiology. While the journal currently holds a Q4 category ranking in the field and occupies a percentile of 24 according to Scopus, it aims to enhance its impact factor by attracting high-quality submissions from researchers and clinicians alike. Kardiologie is particularly focused on bridging the gap between cutting-edge research and clinical practice, ensuring that the latest scientific findings are readily accessible to practitioners. Though it operates under traditional access options at present, the journal aspires to broaden its accessibility and reach in future editions, making it a pertinent choice for anyone interested in the evolving landscape of cardiovascular health.

The International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.

The Journal of the Saudi Heart Association is a prominent scholarly publication dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by DIGITAL COMMONS BEPRESS, this open-access journal has been serving the global community since 2009, providing a vital platform for researchers, practitioners, and students interested in the latest developments in heart health and disease management. With an ISSN of 1016-7315 and a growing repository of knowledge alongside an E-ISSN of 2212-5043, the journal showcases an array of peer-reviewed articles that contribute to the understanding of cardiovascular conditions. Although categorized in the Q4 quartile for 2023, it remains committed to offering valuable insights, particularly within the constraints of the 29th percentile rank specified by Scopus. As the journal converges towards 2024, it continues to foster collaboration, innovation, and inquiry within the Saudi Arabian and international medical communities.